BioNTech SE Weighted Average Fair Value At Measurement Date Share Options Granted
BioNTech SE (BNTX) had Weighted Average Fair Value At Measurement Date Share Options Granted of EUR 116.58 as of 2025-01-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2026-03-10
- 2025-01-31: Weighted Average Fair Value At Measurement Date Share Options Granted 116.58 EUR.
- 2022-05-31: Weighted Average Fair Value At Measurement Date Share Options Granted 42.24 EUR; Weighted Average Fair Value At Measurement Date Share Options Granted as first filed 38.88 EUR.
- 2021-05-17: Weighted Average Fair Value At Measurement Date Share Options Granted 31.61 EUR; Weighted Average Fair Value At Measurement Date Share Options Granted as first filed 27.64 EUR.
- 2021-05-12: Weighted Average Fair Value At Measurement Date Share Options Granted 36.13 EUR; Weighted Average Fair Value At Measurement Date Share Options Granted as first filed 29.05 EUR.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted | Weighted Average Fair Value At Measurement Date Share Options Granted as first filed |
|---|---|---|
| 2025-01-31 | 116.58 EUR 20-F · filed 2026-03-10 | |
| 2022-05-31 | 42.24 EUR 20-F · filed 2025-03-10 | 38.88 EUR 20-F · filed 2024-03-20 |
| 2021-05-17 | 31.61 EUR 20-F · filed 2025-03-10 | 27.64 EUR 20-F · filed 2024-03-20 |
| 2021-05-12 | 36.13 EUR 20-F · filed 2025-03-10 | 29.05 EUR 20-F · filed 2024-03-20 |
| 2020-02-29 | 10.83 EUR 20-F · filed 2025-03-10 |